CFD’er er komplekse instrumenter, og der er en stor risiko forbundet med disse for at miste penge på grund af gearing. 77.3 % af detailinvestorerne har tab på deres konto, når de handler CFD’er med denne udbyder. Du skal overveje, om du forstår, hvordan CFD’er fungerer, og om du har råd til at løbe en stor risiko for at miste dine penge.

Close

Amgen live diagram

Grundlæggende Instrumenter

Weekly Search
Weekly
Daily
Dato Luk Ændring % Ændre Åbn Høj Lav

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Seneste nyheder

Vis mere
Ghko B 2025 Jun 05, 16:00

Trump-Musk Relationship Collapses: Tesla Stock Drops 10%

Stocks
Ghko B 2025 Jun 04, 16:00

SOFI Stock Analysis: What is the 5-year forecast for SoFi?

Stocks
Ghko B 2025 Jun 04, 16:00

VOO Performance Analysis: Is Vanguard S&P 500 ETF good to invest in?

ETFs
Ghko B 2025 Jun 04, 16:00

Intel Stock Is Trending Now: What to Know about Intel Corporation (INTC)?

Stocks
Tommy Yap 2025 Jun 04, 16:00

Morning Note: ECB Rate Cut Expected; Canada PMI in Focus; EUR/USD, USD/CAD

Morning Note Forex CAD
Tommy Yap 2025 Jun 04, 16:00

Morning Note: ECB Rate Cut Expected; Broadcom Earnings; Oil Falls on Supply

Morning Note Tech Commodities
Frances Wang 2025 Jun 03, 16:00

AI Stock Analysis: PLTR Hits Record High as Government Deals Fuel Momentum

Stocks
Frances Wang 2025 Jun 03, 16:00

ACHR Stock Analysis: What’s Driving Archer Aviation's Market Performance?

Stocks

Info

Spread

1.91

Spread (%)

0.6674 %

Gearing

1:5

Dag til dag-rente Køb

-0.0597 %

Dag til dag-rente Sælg

-0.0292 %

Valuta

USD

Åbningstider for handel

Market lukket

Fredag

13:31 - 19:59

Mandag

13:31-19:59

Tirsdag

13:31-19:59

Onsdag

13:31-19:59

Torsdag

13:31-19:59

Analyse og statistikker

Åbn

---

Forrige luk

---

52 uger høj/lav

--- – ---

Markedsværdi

154327007232

Aktier udestående

537705984

Indtjeningsdato (Næste)

1999-11-22

Udbytteprocent

2025-06-06

Ex-udbyttedato

2025-05-16

Forventet årlig udbyttesats

9.52

Forventet årlig udbytteprocent

0.0329

EPS

10.88

Få mere at vide om dette instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Relaterede instrumenter

Aktiv
Sælge
Køb
% Ændre
Relaterede instrumenter

latest_education_articles

Vis mere
Trustpilot